
The Cardiovascular System
From Bench to Bedside
- 1st Edition - July 31, 2025
- Imprint: Academic Press
- Editor: Hussein Hassan Sabit
- Language: English
- Paperback ISBN:9 7 8 - 0 - 4 4 3 - 2 9 8 9 0 - 5
- eBook ISBN:9 7 8 - 0 - 4 4 3 - 2 9 8 9 1 - 2
The series "Stem Cell Innovation in Health & Disease" is a timely and fascinating collection of information and new discoveries and provides a contemporary snapshot album fro… Read more
Purchase options

- Provides cutting-edge research to understand stem cell functions used in disease and disordertreatments of the cardiovascular system
- Develops processes to bring stem cells from bench to bedside
- Includes up to date references on stem cell biology and function in common cardiovascular system diseases and disorders
Zulfugar Timur Taghiyev
2. Innovated Therapeutic Gene Editing Technologies in Stem Cell Engineering and Cardiovascular Disorders and Diseases
Emad Ali Al Khoufi
3. Cardiotoxivity and Cancer Therapy: Mechanisms, Implications, and Mitigation Strategies
Mariam Thabit
4. Advances in stem cell-based therapy of cardiovascular diseases and disorders
ahmed elbarbary
5. Derivation and Application of Embryonic Stem Cells as a Model for Heart Development Diseases and Disorders
Ahmed El-Hashash
6. The Potential of Mesenchymal Stem Cell Related Therapies for Cardiovascular Diseases and Disorders
Connor Case
7. Stem Cell Innovation in Cardiovascular Disease, Repair and Regeneration: General Conclusion, Challenges and Prospective
Ahmed El-Hashash
- Edition: 1
- Published: July 31, 2025
- Imprint: Academic Press
- Language: English
HS
Hussein Hassan Sabit
Hussein Sabit graduated from Ain Shams University, Cairo and received his BSc in Genetics, where he also get his MSc in Microbial Genetics and PhD in Molecular Genetics. He joined Misr University for Science and Technology, Egypt as TA, Assistant Professor. Has been promoted to Associate Professor of Molecular Genetics, and Full Professor in Cancer Epigenetics. His research interest is Cancer Genetic/Epigenetic basis of carcinogenesis, genome editing via CRISPR/Cas9, studying the anti-apoptotic genes and its relations with BC progression, investigating the DNA methylation levels controlling carcinogenesis of BC, studying the chromatin remodelling as a main mechanisms leading to cancer using ChIP assays and others. He published 28 articles; most of them is the main field of Cancer Genetics/Epigenetics. He is the director of Cancer Epigenetics Research Unit (CERU) at MUST, where he leads a research team of postgrad students.